The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.

Varda Space Industries has raised $187 million to accelerate drug development in space using microgravity technology.

Varda Space Industries has announced a successful $187 million funding round, led by Natural Capital and Shrug Capital. The ...

Varda Space Industries has secured $187 million from investors, including Natural Capital and Shrug Capital, to advance its ...

Rooted in Varda’s early photography, the Musée Carnavalet’s show illuminates and clarifies the singular nature of a great ...

Varda Space Industries, which is leveraging reusable rockets to manufacture drugs in low Earth orbit, has received more fuel for its endeavors in the form of a $187 million series C fundraising haul.

The SpaceX program is still in the early stages of development and the plans could change. The effort is highly reliant on ...

NASA officials remain eager for Starliner to begin these regular crew rotation flights, even as its sole destination, the ISS ...

Varda Space Industries, a company developing spacecraft for microgravity life sciences and hypersonics research, has raised ...

One could read the above as a description of Baldwin and Delaney, too, pushing up through the cement of New York, their light ...

Venture capital companies remained the most active space investors in recent months, contributing 77% of 2025 funding in the ...

Synopsys has completed the acquistion of Ansys. The $35bn deal brings Ansys' predictive simulation and analysis tools into ...